Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In Vivo

Table 2

Effect of Pupalia lappacea in blood glucose primed rats.

S. number	Treatment group	Dose (mg/kg)	Blood glucose level (mg/dL)
			0 h	30 min	90 min
1	NC	Untreated	78 ± 3.7	76 ± 2.9	74 ± 1.9
2	GP	Vehicle	87 ± 3.3	184 ± 6.3	152 ± 4.3
3	RF	5.0	90 ± 3.9	152 ± 3.2	96 ± 3.8
4	AS001	250	86 ± 2.9	153 ± 6.2	119 ± 2.6
5	AS002	500	88 ± 2.8	151 ± 3.2	110 ± 1.3

NC = normoglycemic control, GP = glucose primed, and RF = reference group (glibenclamide, 5.0 mg/kg). Values are expressed as mean ± SEM (number of animals, ), significantly different at , when compared with diabetic control group, # refers to “Time post glucose administration”.